Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cephalon Completes Mepha Acquisition | Contract Pharma

What are you searching for?

Sign in
Breaking News

Cephalon Completes Mepha Acquisition

Cephalon, Inc. has completed its acquisition of Mepha, a Swiss-based pharmaceutical company, for approximately $615.4 million.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cephalon, Inc. has completed its acquisition of Mepha, a Swiss-based pharmaceutical company, for approximately $615.4 million. Mepha is now a wholly-owned subsidiary of Cephalon.

“We are proud to include Mepha as part of the Cephalon family. Mepha has a strong reputation for high quality products and services that deliver value to patients and healthcare professionals,” said Frank Baldino, Jr., Ph.D., chairman and chief executive officer of Cephalon. “This acquisition expands our presence in Europe, and we believe Mepha will contribute to our long-term growth.”

Alain Aragues, executive vice president and president of Cephalon Europe, said, “We are pleased to add Mepha’s experience and expertise, which are critical to our successful development of a balanced business mix in Europe, Middle East and Africa. Cephalon intends to leverage Mepha’s brand recognition as the number one generics company in Switzerland and a prominent generic pharmaceutical company in many other markets.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters